Dr. Henske is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney Street
Boston, MA 02115Phone+1 617-632-5320Fax+1 215-214-1023
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1989 - 1991
- Massachusetts General HospitalResidency, Internal Medicine, 1985 - 1989
- Harvard Medical SchoolClass of 1985
Certifications & Licensure
- MA State Medical License 1990 - 2025
- PA State Medical License 1996 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2005
Clinical Trials
- Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis Start of enrollment: 2012 Sep 01
- Safety and Durability of Sirolimus for Treatment of LAM Start of enrollment: 2015 Mar 01
Roles: Contact
Publications & Presentations
PubMed
- 560 citationsTuberous sclerosis complexElizabeth P. Henske, Sergiusz Jóźwiak, J. Christopher Kingswood, Julian R. Sampson, Elizabeth A. Thiele
Nature Reviews. Disease Primers. 2016-05-26 - 335 citationsUnjamming and cell shape in the asthmatic airway epitheliumJin-Ah Park, Jae Hun Kim, Dapeng Bi, Jennifer A. Mitchel, Nader Taheri Qazvini
Nature Materials. 2015-10-01 - 53 citationsEstradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cellsChenggang Li, Po-Shun Lee, Yang Sun, Xiaoxiao Gu, Erik Zhang
The Journal of Experimental Medicine. 2014-01-13
Press Mentions
- First Treatment for a Rare Form of Cancer DiscoveredAugust 3rd, 2022
- Novel Treatment for Rare Form of Kidney Cancer UncoveredJune 21st, 2022
Grant Support
- Summit On Drug Discovery In Tuberous Sclerosis Complex And Related DisordersNational Institute Of Neurological Disorders And Stroke2011
- Roles Of Tuberin (Tsc2), Hamartin (Tsc1), And RHEB In Renal Cyst PathogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
- The Lymphangioleiomyomatosis (Lam)Genome AtlasNational Heart, Lung, And Blood Institute2009–2010
- Regulation Of Estrogen Signaling By Tuberin And RHEBNational Heart, Lung, And Blood Institute2009–2010
- Mechanisms Of Renal Tumorigenesis In Tuberous SclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2008
- Mechanisms Of Renal Tumorigenesis In Tuberous SclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2008
- Regulation Of Estrogen Signaling By Tuberin And RHEBNational Heart, Lung, And Blood Institute2006–2008
- A Schizosaccharomyces Pombe Model Of Birt-Hogg-Dube SyndromeNational Heart, Lung, And Blood Institute2006–2007
- Molecular Basis Of LymphangiomyomatosisNational Heart, Lung, And Blood Institute1999–2006
- Mechanisms Of Renal Malignancy In Tuberous SclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2003
- Renal Cyst Pathogenesis In TSC, VHL, And AdpkdNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
- Renal Cyst Pathogenesis In TSC, VHL, And AdpkdNational Institute Of Diabetes And Digestive And Kidney Diseases1995
- Dystonia And Tuberous Sclerosis--Localization On 9q32-34National Institute Of Neurological Disorders And Stroke1991–1995
External Links
- Henske Labhttp://henskelab.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: